Learn More
Medchemexpress LLC Norethindrone | 68-22-4 | 99.21% | 250 MG

Supplier: Medchemexpress LLC 250MGHYB0554
Norethindrone is a female progestin approved by the FDA for the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea. It is for research use only and not for sale to patients.
- Approved by FDA for the treatment of endometriosis, uterine bleeding, and secondary amenorrhea
- Acts as a female progestin
- Agonistic activity for modulation of human progesterone receptor (hPR-B)
- Cost-effective alternative for symptomatic endometriosis
- Well-tolerated and effective for managing pain and bleeding in all stages of endometriosis
- Shows low acute toxicity in experimental animals
- Inhibits incorporation of palmitate and glycerol into triglycerides of isolated hepatocytes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.